Results 181 to 190 of about 49,785 (245)

Personalized Cancer Vaccines in the Clinical Trial Pipeline

open access: yesAsia-Pacific Journal of Clinical Oncology, Volume 22, Issue 3, Page 362-368, June 2026.
ABSTRACT Aim To present an overview of personalized cancer vaccines currently undergoing clinical development, aiming to enhance awareness and promote collaboration among academic, commercial researchers, and non‐profit communities. Methods A dataset of 78 clinical trials for personalized cancer vaccines was generated using ClinicalTrials.gov database ...
Liudmila Iamukova, Elena Alferova
wiley   +1 more source

Safety, tolerability, pharmacokinetics and pharmacodynamics of the spleen tyrosine kinase inhibitor BI 894416 in healthy volunteers and patients with asthma

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 11, Page 2660-2674, June 2026.
Abstract Background and Purpose Spleen tyrosine kinase (SYK) has broad biological functions in inflammation and immunity. The orally administered SYK inhibitor BI 894416 was investigated in a single‐rising‐dose Phase I study in healthy volunteers and in a combined single‐ and multiple‐rising‐dose Phase Ib study in patients with mild asthma ...
Saskia Carstensen‐Aurèche   +8 more
wiley   +1 more source

Psychopathological Burden in Allergic Contact Dermatitis: Results From a Case–Control Study Using the SCL‐90‐R

open access: yesContact Dermatitis, Volume 94, Issue 6, Page 603-613, June 2026.
This case–control study shows that patients with allergic contact dermatitis have a higher burden of psychopathological symptoms than controls, particularly in phobic anxiety and somatization, highlighting the frequent coexistence of psychological distress in allergic contact dermatitis.
Francisco José Navarro‐Triviño   +3 more
wiley   +1 more source

Heterogeneity in clinical appearance of chronic spontaneous urticaria: A cross-sectional analysis of a retrospective cohort. [PDF]

open access: yesWorld Allergy Organ J
Toprak İD   +9 more
europepmc   +1 more source

Dupilumab in Patients With Chronic Spontaneous Urticaria: Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials.

open access: yesJAMA Dermatol
Casale TB   +12 more
europepmc   +1 more source

How to Reduce Wheat Allergens and FODMAPs in Foods: A Critical Review of Patents

open access: yesCereal Chemistry, Volume 103, Issue 3, Page 253-266, May/June 2026.
ABSTRACT Background and Objectives Supported by scientific evidence, this critical review of the patent literature examined methods to reduce wheat allergens and FODMAPs in foods, which may trigger digestive disorders and other health problems. The following topics were covered: proteolytic enzymes, proteolytic bacteria and yeasts, separation, plant ...
Pierre Gélinas, Jérémie Théolier
wiley   +1 more source

Home - About - Disclaimer - Privacy